<DOC>
	<DOC>NCT00780429</DOC>
	<brief_summary>Study of the pharmacokinetic and pharmacodynamic variability of mycophenolate mofetil in renal transplant patients already on long-term MMF treatment (at least 6 months post-transplant; at least 3 months in therapy). Study hypothesis: to investigate whether long-term MMF therapy alters IMPDH biological activity and if there are any correlations with the risk of AR.</brief_summary>
	<brief_title>Pharmacokinetics and Pharmacodynamics of MPA in Stable Renal Transplant Patients</brief_title>
	<detailed_description />
	<mesh_term>Mycophenolic Acid</mesh_term>
	<mesh_term>Mycophenolate mofetil</mesh_term>
	<criteria>Renal transplant recipients Age range: 1870 Patients taking MMF Able to understand and sign an informed consent Active myelodepression Systemic infections or other that may affect MMF absorption Pregnancy/breastfeeding (History of) cancer Drug abuse, psychiatric conditions Already enrolled in other clinical trials or participation ended less than one month earlier Known sensitivity to polysorbate 80 or MMF</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>October 2008</verification_date>
	<keyword>kidney</keyword>
	<keyword>transplant</keyword>
	<keyword>Mycophenolic acid</keyword>
	<keyword>Inosine monophosphate dehydrogenase</keyword>
</DOC>